Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1

Caixia Hou, Stevi Weidenbach, Kristin E. Cano, Zhonghua Wang, Prithiba Mitra, Dmitri N Ivanov, Jürgen Rohr, Oleg V. Tsodikov

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Transcription factors have been considered undruggable, but this paradigm has been recently challenged. DNA binding natural product mithramycin (MTM) is a potent antagonist of oncogenic transcription factor EWS-FLI1. Structural details of MTM recognition of DNA, including the FLI1 binding sequence GGA(A/T), are needed to understand how MTM interferes with EWS-FLI1. We report a crystal structure of an MTM analogue MTM SA-Trp bound to a DNA oligomer containing a site GGCC, and two structures of a novel analogue MTM SA-Phe in complex with DNA. MTM SA-Phe is bound to sites AGGG and GGGT on one DNA, and to AGGG and GGGA(T) (a FLI1 binding site) on the other, revealing how MTM recognizes different DNA sequences. Unexpectedly, at sub-micromolar concentrations MTMs stabilize FLI1-DNA complex on GGAA repeats, which are critical for the oncogenic function of EWS-FLI1. We also directly demonstrate by nuclear magnetic resonance formation of a ternary FLI1-DNA-MTM complex on a single GGAA FLI1/MTM binding site. These biochemical and structural data and a new FLI1-DNA structure suggest that MTM binds the minor groove and perturbs FLI1 bound nearby in the major groove. This ternary complex model may lead to development of novel MTM analogues that selectively target EWS-FLI1 or other oncogenic transcription factors, as anti-cancer therapeutics.

Original languageEnglish (US)
Pages (from-to)8990-9004
Number of pages15
JournalNucleic Acids Research
Volume44
Issue number18
DOIs
StatePublished - Oct 14 2016

Fingerprint

Plicamycin
Transcription Factors
DNA
Binding Sites
Biological Products

ASJC Scopus subject areas

  • Genetics

Cite this

Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1. / Hou, Caixia; Weidenbach, Stevi; Cano, Kristin E.; Wang, Zhonghua; Mitra, Prithiba; Ivanov, Dmitri N; Rohr, Jürgen; Tsodikov, Oleg V.

In: Nucleic Acids Research, Vol. 44, No. 18, 14.10.2016, p. 8990-9004.

Research output: Contribution to journalArticle

Hou, C, Weidenbach, S, Cano, KE, Wang, Z, Mitra, P, Ivanov, DN, Rohr, J & Tsodikov, OV 2016, 'Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1', Nucleic Acids Research, vol. 44, no. 18, pp. 8990-9004. https://doi.org/10.1093/nar/gkw761
Hou, Caixia ; Weidenbach, Stevi ; Cano, Kristin E. ; Wang, Zhonghua ; Mitra, Prithiba ; Ivanov, Dmitri N ; Rohr, Jürgen ; Tsodikov, Oleg V. / Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1. In: Nucleic Acids Research. 2016 ; Vol. 44, No. 18. pp. 8990-9004.
@article{91975c672f994f90be5fe71e1b0af79d,
title = "Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1",
abstract = "Transcription factors have been considered undruggable, but this paradigm has been recently challenged. DNA binding natural product mithramycin (MTM) is a potent antagonist of oncogenic transcription factor EWS-FLI1. Structural details of MTM recognition of DNA, including the FLI1 binding sequence GGA(A/T), are needed to understand how MTM interferes with EWS-FLI1. We report a crystal structure of an MTM analogue MTM SA-Trp bound to a DNA oligomer containing a site GGCC, and two structures of a novel analogue MTM SA-Phe in complex with DNA. MTM SA-Phe is bound to sites AGGG and GGGT on one DNA, and to AGGG and GGGA(T) (a FLI1 binding site) on the other, revealing how MTM recognizes different DNA sequences. Unexpectedly, at sub-micromolar concentrations MTMs stabilize FLI1-DNA complex on GGAA repeats, which are critical for the oncogenic function of EWS-FLI1. We also directly demonstrate by nuclear magnetic resonance formation of a ternary FLI1-DNA-MTM complex on a single GGAA FLI1/MTM binding site. These biochemical and structural data and a new FLI1-DNA structure suggest that MTM binds the minor groove and perturbs FLI1 bound nearby in the major groove. This ternary complex model may lead to development of novel MTM analogues that selectively target EWS-FLI1 or other oncogenic transcription factors, as anti-cancer therapeutics.",
author = "Caixia Hou and Stevi Weidenbach and Cano, {Kristin E.} and Zhonghua Wang and Prithiba Mitra and Ivanov, {Dmitri N} and J{\"u}rgen Rohr and Tsodikov, {Oleg V.}",
year = "2016",
month = "10",
day = "14",
doi = "10.1093/nar/gkw761",
language = "English (US)",
volume = "44",
pages = "8990--9004",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "18",

}

TY - JOUR

T1 - Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1

AU - Hou, Caixia

AU - Weidenbach, Stevi

AU - Cano, Kristin E.

AU - Wang, Zhonghua

AU - Mitra, Prithiba

AU - Ivanov, Dmitri N

AU - Rohr, Jürgen

AU - Tsodikov, Oleg V.

PY - 2016/10/14

Y1 - 2016/10/14

N2 - Transcription factors have been considered undruggable, but this paradigm has been recently challenged. DNA binding natural product mithramycin (MTM) is a potent antagonist of oncogenic transcription factor EWS-FLI1. Structural details of MTM recognition of DNA, including the FLI1 binding sequence GGA(A/T), are needed to understand how MTM interferes with EWS-FLI1. We report a crystal structure of an MTM analogue MTM SA-Trp bound to a DNA oligomer containing a site GGCC, and two structures of a novel analogue MTM SA-Phe in complex with DNA. MTM SA-Phe is bound to sites AGGG and GGGT on one DNA, and to AGGG and GGGA(T) (a FLI1 binding site) on the other, revealing how MTM recognizes different DNA sequences. Unexpectedly, at sub-micromolar concentrations MTMs stabilize FLI1-DNA complex on GGAA repeats, which are critical for the oncogenic function of EWS-FLI1. We also directly demonstrate by nuclear magnetic resonance formation of a ternary FLI1-DNA-MTM complex on a single GGAA FLI1/MTM binding site. These biochemical and structural data and a new FLI1-DNA structure suggest that MTM binds the minor groove and perturbs FLI1 bound nearby in the major groove. This ternary complex model may lead to development of novel MTM analogues that selectively target EWS-FLI1 or other oncogenic transcription factors, as anti-cancer therapeutics.

AB - Transcription factors have been considered undruggable, but this paradigm has been recently challenged. DNA binding natural product mithramycin (MTM) is a potent antagonist of oncogenic transcription factor EWS-FLI1. Structural details of MTM recognition of DNA, including the FLI1 binding sequence GGA(A/T), are needed to understand how MTM interferes with EWS-FLI1. We report a crystal structure of an MTM analogue MTM SA-Trp bound to a DNA oligomer containing a site GGCC, and two structures of a novel analogue MTM SA-Phe in complex with DNA. MTM SA-Phe is bound to sites AGGG and GGGT on one DNA, and to AGGG and GGGA(T) (a FLI1 binding site) on the other, revealing how MTM recognizes different DNA sequences. Unexpectedly, at sub-micromolar concentrations MTMs stabilize FLI1-DNA complex on GGAA repeats, which are critical for the oncogenic function of EWS-FLI1. We also directly demonstrate by nuclear magnetic resonance formation of a ternary FLI1-DNA-MTM complex on a single GGAA FLI1/MTM binding site. These biochemical and structural data and a new FLI1-DNA structure suggest that MTM binds the minor groove and perturbs FLI1 bound nearby in the major groove. This ternary complex model may lead to development of novel MTM analogues that selectively target EWS-FLI1 or other oncogenic transcription factors, as anti-cancer therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=84992365793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992365793&partnerID=8YFLogxK

U2 - 10.1093/nar/gkw761

DO - 10.1093/nar/gkw761

M3 - Article

C2 - 27587584

AN - SCOPUS:84992365793

VL - 44

SP - 8990

EP - 9004

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 18

ER -